Animal Genetics Market Overview
The Global Animal Genetics Market is expected to witness steady growth through 2031, supported by the increasing demand for high-quality livestock, advancements in genetic technologies, and the growing need for sustainable animal production. Rising consumption of animal-derived food products, expanding livestock populations, and greater emphasis on disease-resistant breeds are encouraging the adoption of advanced animal genetics solutions across the agriculture and veterinary sectors.
Animal genetics focuses on understanding and improving the genetic characteristics of livestock, poultry, companion animals, and other species. The field combines molecular biology, genomics, reproductive technologies, and breeding strategies to enhance productivity, improve disease resistance, strengthen reproductive performance, and optimize overall animal health.
Modern animal genetics plays a vital role in livestock improvement by enabling farmers and breeders to develop animals with desirable characteristics such as faster growth, higher milk yield, superior meat quality, improved fertility, and greater resistance to infectious diseases.
Increasing investments in livestock modernization and precision breeding are further accelerating the adoption of genetic technologies worldwide.
Get Free Sample Report: https://meditechinsights.com/animal-genetics-market/request-sample/
Market Trends
The shift from conventional breeding methods to advanced reproductive technologies is transforming the animal genetics industry.
Artificial insemination, embryo transfer, in vitro fertilization (IVF), and cryopreservation are increasingly replacing traditional breeding practices due to their higher efficiency and improved genetic outcomes.
Genome editing technologies, particularly CRISPR-Cas9, are revolutionizing livestock breeding by enabling precise genetic modifications that improve productivity, disease resistance, and animal welfare.
Genomic selection has become an essential tool for identifying superior breeding animals based on DNA analysis rather than physical traits alone.
The use of molecular diagnostics and genomic testing is expanding rapidly, allowing breeders to detect inherited disorders, identify valuable genetic traits, and make informed breeding decisions.
Precision breeding techniques are gaining popularity because they enable faster genetic improvement while preserving valuable livestock characteristics.
Growing interest in transgenic animal research is supporting advancements in biomedical research, vaccine production, and pharmaceutical development.
Market Drivers
The increasing global demand for meat, milk, eggs, and other animal-derived protein products remains one of the primary drivers of market growth.
Rapid population growth, changing dietary habits, and rising disposable incomes are encouraging higher livestock production to meet global food demand.
Government initiatives promoting livestock improvement programs and modern breeding technologies are supporting wider adoption of animal genetics solutions.
Many countries are investing in genomic selection, artificial insemination programs, sex-sorted semen technology, and embryo transfer to improve livestock productivity and food security.
The growing prevalence of inherited diseases in livestock has increased demand for advanced genetic testing and disease screening solutions.
Continuous innovation in DNA sequencing, molecular diagnostics, and genomic analysis is improving breeding accuracy and accelerating genetic improvement programs.
Increasing collaboration between biotechnology companies, veterinary organizations, and livestock producers is strengthening research and commercialization of advanced genetic technologies.
Market Opportunities
The growing adoption of precision livestock farming creates significant opportunities for genetic testing, genomic selection, and digital breeding management.
Expanding dairy, poultry, aquaculture, and swine industries are increasing demand for genetically superior breeding stock capable of delivering higher productivity.
Advancements in genome sequencing and bioinformatics are enabling more accurate identification of desirable genetic traits across multiple animal species.
Emerging economies are investing heavily in livestock modernization, creating attractive growth opportunities for animal genetics companies.
The integration of artificial intelligence, genomic databases, and predictive analytics is expected to improve breeding decisions and accelerate genetic progress.
Increasing focus on sustainable livestock production is encouraging the development of animals with improved feed efficiency and lower environmental impact.
Growing demand for companion animal genetic testing is opening new opportunities beyond traditional livestock applications.
Market Challenges
Limited availability of skilled professionals with expertise in animal genomics and reproductive technologies remains a challenge in several developing regions.
Inadequate veterinary infrastructure and limited access to advanced breeding facilities can restrict market growth, particularly in rural areas.
The high cost of advanced genetic testing, genome sequencing, and reproductive technologies may limit adoption among small-scale livestock producers.
Ethical concerns surrounding genetic modification and genome editing continue to influence public perception and regulatory policies.
Variations in regulatory frameworks across countries may delay commercialization of genetically improved animal products.
Protecting genetic diversity while achieving productivity improvements remains an important consideration for breeders and researchers.
Regional Analysis
North America holds a significant share of the Animal Genetics Market due to advanced livestock farming practices, strong biotechnology capabilities, and widespread adoption of genomic technologies.
Europe continues to be a major market supported by established breeding programs, favorable government initiatives, and increasing investments in sustainable livestock production.
Asia-Pacific is expected to register the fastest growth during the forecast period owing to expanding livestock populations, rising demand for animal protein, improving veterinary healthcare infrastructure, and increasing government support for genetic improvement programs.
China and India are witnessing significant investments in dairy and poultry modernization, while Australia and New Zealand continue to adopt advanced breeding technologies for livestock improvement.
Latin America is experiencing steady market expansion driven by the growth of beef and poultry industries and increasing focus on genetic enhancement.
The Middle East and Africa are gradually adopting modern breeding technologies to improve livestock productivity and strengthen food security.
Competitive Landscape
The Animal Genetics Market is highly competitive, with leading companies focusing on genomic innovation, reproductive technologies, strategic acquisitions, and expansion of genetic testing portfolios.
Manufacturers continue to invest in research and development to introduce more accurate genomic tests, improve breeding efficiency, and develop disease-resistant livestock.
Collaborations between biotechnology companies, research institutions, veterinary organizations, and livestock producers are accelerating innovation and expanding access to advanced animal genetics solutions.
The increasing commercialization of genomic testing services and reproductive technologies is expected to strengthen competition and drive continuous product innovation.
Competitive Dynamics & Leading Players
- Genus plc (PIC & ABS Global)
- Pioneering Gene-Edited Porcine Lines: Operates PIC (porcine genetics) and ABS Global (bovine genetics). Genus achieved a commercial breakthrough with its PRRS-resistant pig (developed using CRISPR gene editing to knock out the CD163 viral receptor), establishing a global precedent for gene-edited food animals.
- Sexed Semen Growth: Expanded proprietary Sexcel® sexed bovine genetics, competing globally with flow-cytometry leaders.
- Zoetis Inc. & Neogen Corporation
- Genomics Market Consolidation: In 2026, Zoetis initiated the acquisition of the global animal genomic testing business of Neogen Corporation, a transaction consolidating cattle and companion animal DNA testing portfolios (including Neogen’s Igenity® and GeneSeek platforms alongside Zoetis’s Clarifide® family).
- Integrative Herd Management: Integrating genomic profiling with farm management software, herd health records, and predictive wellness analytics.
- URUS Group (Alta Genetics, GENEX, PEAK)
- Bovine Dominance: One of the world’s largest dairy and beef cattle breeding organizations. Focuses on custom dairy-beef crossbreeding programs (Beef-on-Dairy) using tailored terminal sires to maximize carcass value from dairy herds while utilizing sexed dairy semen for replacement heifers.
- STgenetics (Sexing Technologies)
- Sexed Semen Technology: The pioneer and standard-setter in flow-cytometric cell sorting technology for livestock sperm (SexedULTRA™). Continues to license sorting hardware and consumables worldwide while expanding its own elite genetic nucleus herds.
- Hendrix Genetics & EW Group
- Multi-Species Footprint: Hendrix Genetics consolidated its swine breeding operations following the integration of Hypor and Danish Genetics, complementing its global leadership in layer poultry (ISA, Dekalb), turkey breeding, and aquaculture genetics.
- Avian Pedigrees: EW Group (via Aviagen) maintains dominant global market share in commercial broiler poultry parent stock (Ross and Cobb lines).
Recent Developments:
- October 2026 — Canadian Regulatory Clearance for PRRS-Resistant Pigs: Health Canada and the Canadian Food Inspection Agency (CFIA) determined that PIC’s gene-edited, PRRS-resistant pigs are safe for food consumption, manufacturing, and import, mirroring U.S. approvals and establishing a North American corridor for gene-edited pork.
- September 2026 — Hendrix Genetics Consolidates Global Swine Division: Hendrix Genetics completed the full ownership buyout and unified operational consolidation of its global swine business unit, streamlining international distribution for its combined Hypor and Danish Genetics breeding stock.
- March 2026 — Zoetis Agrees to Acquire Neogen’s Animal Genomics Business: Zoetis signed a definitive agreement to acquire Neogen’s global animal genomics unit, combining the two largest commercial livestock genotyping platforms and centralizing high-throughput SNP screening labs across North America, Europe, and Australasia.
Structural Trends Shaping the Industry
- Regulatory Thaw for Precision Gene Editing: The U.S. FDA and international clearances of PIC’s PRRS-resistant pigs marked a transition from conventional selection to non-transgenic CRISPR gene editing. Regulators increasingly distinguish between targeted gene deletion (which leaves no foreign DNA) and traditional GMO transgenics, opening pathways for traits addressing African Swine Fever (ASF) and heat resilience.
- The “Beef-on-Dairy” Revolution: Driven by high-purity sexed semen technologies, dairy farmers can reliably generate 100% of their replacement heifers from their top 20%–30% genetically ranked cows. The remaining cows are bred using high-index beef semen (Angus, Simmental, Wagyu), creating crossbred calves that command steep premiums in the beef feedlot supply chain.
- Methane Efficiency and Environmental Phenotyping: Breeding indexes are evolving beyond raw production yield to incorporate sustainability metrics. National databases and breeding companies have incorporated genomic markers for lower enteric methane emissions, reduced nitrogen output, and heat-tolerance phenotypes (e.g., slick-coat genes) to meet global agricultural decarbonization targets.
Key Request a free sample copy or view report summary: https://meditechinsights.com/animal-genetics-market/request-sample/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
